Market Research Reports, Inc. has announced the addition of “Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016” research report to their website www.MarketResearchReports.com

Lewes, DE -- (SBWire) -- 09/27/2016 --Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) pipeline Target constitutes close to 5 molecules. Out of which approximately 2 molecules are developed by Companies and remaining by the Universities/Institutes. Publisher's latest report Heme Oxygenase 1 – Pipeline Review, H2 2016, outlays comprehensive information on the Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Heme oxygenase 1 is an enzyme encoded by HMOX1 gene. Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. It exhibits cytoprotective effects since excess of free heme sensitizes cells to undergo apoptosis. The molecules developed by Companies in Preclinical and Discovery stages are 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 2 molecules, respectively.

Furthermore, this report also reviews key players involved in Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Driven by data built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

For more information Visit at: http://www.marketresearchreports.com/global-markets-direct/heme-oxygenase-1-ho1-or-hmox1-or-ec-1141418-pipeline-review-h2-2016

Related Reports;

Maternal Embryonic Leucine Zipper Kinase (Protein Kinase Eg3 or Tyrosine Protein Kinase MELK or Protein Kinase PK38 or MELK or EC 2.7.11.1) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/maternal-embryonic-leucine-zipper-kinase-protein-kinase-eg3-or-tyrosine

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/hepatitis-virus-cellular-receptor-2-t-cell-immunoglobulin-and-mucin-domain

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/hepcidin-liver-expressed-antimicrobial-peptide-1-or-putative-liver-tumor

Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Pipeline Review, H2 2016 - http://www.marketresearchreports.com/global-markets-direct/protein-kinase-c-theta-type-npkc-theta-or-prkcq-or-ec-271113-pipeline-review

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions